Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Individualization of the First Vancomycin Dose Using Population Pharmacokinetic Models.

NCT05964114 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05964114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05964114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Individualization of the First Vancomycin Dose Using Population Pharmacokinetic Models.
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2023
Completion date
June 30, 2026
Enrollment
134 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics, vancomycin